Monitoring of gene expression in patients with rheumatoid arthritis treated with anti-CD20 (Rituximab) applying DNA-CHIP technology

被引：0
|
作者：
Drynda, S.
Drynda, A.
Koczan, D.
Thiesen, H.
Kekow, J.
机构：
[1] Univ Magdeburg, D-39106 Magdeburg, Germany
[2] Univ Rostock, Inst Immunol, Rostock, Germany
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：188 / 189
页数：2
相关论文
共 50 条
  • [1] Modulation of gene expression profiles of pbmc in rheumatoid arthritis patients treated with anti-CD20 (rituximab)
    Drynda, S.
    Koczan, D.
    Thiesen, H. J.
    Kekow, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : A29 - A29
  • [2] Monitoring of gene expression of patients with juvenile idiopathic arthritis (JIA) treated with anti-TNFα applying DNA-chip technology.
    Kekow, J
    Koczan, D
    Kekow, M
    Drynda, S
    Thiesen, HJ
    Guthke, R
    Oppermann, J
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S364 - S364
  • [3] Anti-CD20 Antibody Rituximab in the Treatment of Rheumatoid Arthritis
    Korhonen, Riku
    Moilanen, Eeva
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106 (01) : 13 - 21
  • [4] Anti-CD20 for rheumatoid arthritis
    Edwards, JC
    Leandro, MJ
    Cambridge, G
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 25 - 25
  • [5] B cell therapy for rheumatoid arthritis: the rituximab (anti-CD20) experience
    Shaw, T
    Quan, J
    Totoritis, MC
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 55 - 59
  • [6] Anti-CD20 therapy in rheumatoid arthritis
    Roll, P.
    Tony, H. -P.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (05): : 370 - +
  • [7] Aneugenic and clastogenic alterations in the DBA/IJ mouse model of rheumatoid arthritis treated with rituximab, an anti-CD20 antibody
    Attia, Sabry M.
    Al-Hamamah, Mohammed A.
    Alotaibi, Moureq R.
    Alasmari, Abdullah F.
    Attia, Mohamed S. M.
    Ahmad, Sheikh F.
    Mahmoud, Mohamed A.
    Nadeem, Ahmed
    Ansari, Mushtaq A.
    Bakheet, Saleh A.
    [J]. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2023, 888
  • [8] THE INVESTIGATION OF INFLUENCE OF THE TREATMENT WITH ANTI-CD20 ANTIBODIES (RITUXIMAB) ON BONE MINERAL DENSITY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Dydykina, P.
    Dydykina, I.
    Devyataikina, A.
    Lukina, G.
    Smimov, A.
    Nasonov, E.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S262 - S262
  • [9] Anti-CD20 therapy in rheumatoid arthritis [Anti-CD20-Therapie bei rheumatoider Arthritis]
    Roll P.
    Tony H.-P.
    [J]. Zeitschrift für Rheumatologie, 2009, 68 (5) : 370 - 379
  • [10] Current aspects of anti-CD20 therapy in rheumatoid arthritis
    Jacobi, Annett M.
    Doerner, Thomas
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2010, 10 (03) : 316 - 321
12345